Study of EBT-101 in Aviremic HIV-1 Infected Adults on Stable ART
Clinical trial NCT05144386 · COMPLETED
Trial details
- NCT number
- NCT05144386
- Sponsor
- Excision BioTherapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-24
- Primary completion
- 2024-11-14
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.